Immune tolerance in patients with hemophilia A and longstanding inhibitors

被引：0
|
作者：
Dunn, A. L. [1 ]
Meeks, S. L. [1 ]
Chapman, R. L. [1 ]
Kempton, C. L. [1 ]
机构：
[1] Emory Univ, Pediat, Atlanta, GA 30322 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-587
引用
收藏
页码：518 / 519
页数：2
相关论文
共 50 条
  • [31] INDUCTION OF IMMUNE TOLERANCE IN HEMOPHILIA
    LARRIEU, MJ
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 62 - 62
  • [32] Tolerance to factor VIII inhibitors in hemophilia a patients: A French twist
    Pascual, V
    Capra, JD
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (06): : 1357 - 1358
  • [33] Induction of prolonged immune tolerance to FVIII in an animal model of hemophilia inhibitors.
    Harrison, JA
    Jarvis, MA
    Brown, JE
    Powell, JS
    BLOOD, 1997, 90 (10) : 3137 - 3137
  • [34] The economic impact of anamnestic response in the management of hemophilia patients with inhibitors undergoing immune tolerance induction in germany.
    Odeyemi, Isaac
    Moller, Anne D.
    BLOOD, 2007, 110 (11) : 373B - 373B
  • [35] Immune Tolerance Induction Therapy for Patients With Hemophilia A and FVIII Inhibitors Particularly Using Low-Dose Regimens
    Lin, Pei-Chin
    Liao, Yu-Mei
    Tsai, Shih-Pien
    Chang, Tai-Tsung
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1029 - 1033
  • [36] The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors
    Yoshioka, Akira
    Ishii, Eizaburo
    Ueno, Tamaki
    Usami, Ikuya
    Kobayashi, Masao
    Kobayashi, Ryoji
    Sotomatsu, Manabu
    Shirahata, Akira
    Suzuki, Takashi
    Taki, Masashi
    Ishida, Yasushi
    Matsushita, Tadashi
    Shima, Midori
    Nogami, Keiji
    Sakai, Michio
    Kigasawa, Hisato
    Fukutake, Katsuyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (04) : 362 - 368
  • [37] Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study
    Santagostino, E.
    Coppola, A.
    Rocino, A.
    Mancuso, M.
    Tagliaferri, A.
    Scaraggi, F.
    Biasoli, C.
    Messina, M.
    Iorio, A.
    Mancuso, G.
    HAEMOPHILIA, 2008, 14 : 57 - 57
  • [38] IMMUNE TOLERANCE INDUCTION WITH NUWIQ® (SIM OCT OCOG ALFA) IN NINE PATIENTS WITH SEVERE HEMOPHILIA A AND INHIBITORS TO FVIII
    Liesner, R. J.
    Wilkinson, A.
    Mathias, M.
    Bhatnagar, N.
    Hall, G. W.
    HAEMATOLOGICA, 2019, 104 : 14 - 14
  • [39] The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors
    Akira Yoshioka
    Eizaburo Ishii
    Tamaki Ueno
    Ikuya Usami
    Masao Kobayashi
    Ryoji Kobayashi
    Manabu Sotomatsu
    Akira Shirahata
    Takashi Suzuki
    Masashi Taki
    Yasushi Ishida
    Tadashi Matsushita
    Midori Shima
    Keiji Nogami
    Michio Sakai
    Hisato Kigasawa
    Katsuyuki Fukutake
    International Journal of Hematology, 2015, 101 : 362 - 368
  • [40] Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia. Patients with High-Responding Inhibitors
    Prezotti, Alessandra N. L.
    Ferreira, Clarissa
    Oliveira, Luciana
    Lorenzato, Claudia
    Orletti, Maria P. S. V.
    Roberti, Maria do Rosario
    Ribeiro, Rosangela
    Villaca, Paula Ribeiro
    Montalvao, Silmara Aparecida De Lima
    Medina, Samuel S.
    Hayakawa, Gabriela G. Yamaguti
    Ozelo, Margareth C.
    BLOOD, 2017, 130
12345